These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22160904)

  • 1. Plasmid DNA production for therapeutic applications.
    Lara AR; Ramírez OT; Wunderlich M
    Methods Mol Biol; 2012; 824():271-303. PubMed ID: 22160904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid Replicons for the Production of Pharmaceutical-Grade pDNA, Proteins and Antigens by
    Duarte SOD; Monteiro GA
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in host and vector development for the production of plasmid DNA vaccines.
    Mairhofer J; Lara AR
    Methods Mol Biol; 2014; 1139():505-41. PubMed ID: 24619702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and purification of plasmid DNA vaccines: is there scope for further innovation?
    Xenopoulos A; Pattnaik P
    Expert Rev Vaccines; 2014 Dec; 13(12):1537-51. PubMed ID: 25308708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marker-free plasmids for biotechnological applications - implications and perspectives.
    Oliveira PH; Mairhofer J
    Trends Biotechnol; 2013 Sep; 31(9):539-47. PubMed ID: 23830144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of new plasmid DNA vaccine vectors with R1-based replicons.
    Bower DM; Prather KL
    Microb Cell Fact; 2012 Aug; 11():107. PubMed ID: 22889338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization and delivery of plasmid DNA for vaccination.
    Jechlinger W
    Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Vaccination in Chickens.
    Gupta SK; Dey S; Chellappa MM
    Methods Mol Biol; 2016; 1404():165-178. PubMed ID: 27076297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccine design.
    Brandsma JL
    Methods Mol Med; 2006; 127():3-10. PubMed ID: 16988442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minicircle: Next Generation DNA Vectors for Vaccination.
    Schleef M; Schirmbeck R; Reiser M; Michel ML; Schmeer M
    Methods Mol Biol; 2015; 1317():327-39. PubMed ID: 26072415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful application of monolithic innovative technology using a carbonyldiimidazole disk to purify supercoiled plasmid DNA suitable for pharmaceutical applications.
    Sousa A; Tomaz CT; Sousa F; Queiroz JA
    J Chromatogr A; 2011 Nov; 1218(46):8333-43. PubMed ID: 21995857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the immune response to genetic immunization.
    Cohen AD; Boyer JD; Weiner DB
    FASEB J; 1998 Dec; 12(15):1611-26. PubMed ID: 9837851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines: vector design, delivery, and antigen presentation.
    Feltquate DM
    J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a single hydrophobic-interaction chromatography to purify pharmaceutical-grade supercoiled plasmid DNA from other isoforms.
    Bo H; Wang J; Chen Q; Shen H; Wu F; Shao H; Huang S
    Pharm Biol; 2013 Jan; 51(1):42-8. PubMed ID: 23013372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upstream processing of plasmid DNA for vaccine and gene therapy applications.
    Tejeda-Mansir A; Montesinos RM
    Recent Pat Biotechnol; 2008; 2(3):156-72. PubMed ID: 19075863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination model.
    Nguyen-Hoai T; Baldenhofer G; Ahmed MS; Pham-Duc M; Gries M; Lipp M; Dörken B; Pezzutto A; Westermann J
    J Gene Med; 2012 Feb; 14(2):128-37. PubMed ID: 22228591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines: successes and limitations in cancer and infectious disease.
    Lowe DB; Shearer MH; Kennedy RC
    J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.